Pfizer Manufacturing Deutschland is an API and finished-dose manufacturer based in Germany. It appears in 85 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and INVIMA (CO). Its GMP standing is certified by ZLG (DE), ANVISA (Brazil) and MFDS (Korea), among 6 authorities. Its most recent recorded inspection, by US FDA, closed on 11 May 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Freiburg, United Arab Emirates | Not on file |
| FREIBURG, Germany | Not on file |
| Freiburg Im Breisgau, Germany | Not on file |
| Baden-Wuerttemberg, Germany | Not on file |
| Germany, Germany | 3002807097 |
| Molecule | Regulators | Docs |
|---|---|---|
| Celecoxib | SFDA (Saudi Arabia) | 1 |
| Crizotinib | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 32 | None |
| MINSA (CR) | 24 | None |
| INVIMA (CO) | 14 | None |
| NAFDAC (NG) | 14 | None |
| JFDA (JO) | 1 | None |
| ZLG (DE) | None | 4 |
| ANVISA (Brazil) | None | 3 |
| MFDS (Korea) | None | 2 |
| US FDA | None | 1 |
| EAEU_EEC | None | 1 |
| EMA | None | 1 |
Choose your molecules and target markets. Pfizer Manufacturing Deutschland comes back tiered against every other supplier able to file there.
Start for free